R&D Sponsored Clinical trial trends and the rise of site networks We've recently passed the midpoint of 2024, so it's a good time to check in on trends – in this case, trends in the clinical trial space.
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.